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Abstract
Background: Late diagnosis of HIV infection is a major challenge to the scale-up of HIV prevention and treatment. In 2005
Uganda adopted provider-initiated HIV testing in the health care setting to ensure earlier HIV diagnosis and linkage to care.
We provided HIV testing to patients at Mulago hospital in Uganda, and performed CD4 tests to assess disease stage at
diagnosis.
Methods: Patients who had never tested for HIV or tested negative over one year prior to recruitment were enrolled
between May 2008 and March 2010. Participants who tested HIV positive had a blood draw for CD4. Late HIV diagnosis was
defined as CD4#250 cells/mm. Predictors of late HIV diagnosis were analyzed using multi-variable logistic regression.
Results: Of 1966 participants, 616 (31.3%) were HIV infected; 47.6% of these (291) had CD4 counts #250. Overall, 66.7%
(408) of the HIV infected participants had never received care in a medical clinic. Receiving care in a non-medical setting
(home, traditional healer and drug stores) had a threefold increase in the odds of late diagnosis (OR=3.2; 95%CI: 2.1–4.9)
compared to receiving no health care.
Conclusions: Late HIV diagnosis remains prevalent five years after introducing provider-initiated HIV testing in Uganda.
Many individuals diagnosed with advanced HIV did not have prior exposure to medical clinics and could not have
benefitted from the expansion of provider initiated HIV testing within health facilities. In addition to provider-initiated
testing, approaches that reach individuals using non-hospital based encounters should be expanded to ensure early HIV
diagnosis.
Citation: Wanyenze RK, Kamya MR, Fatch R, Mayanja-Kizza H, Baveewo S, et al. (2011) Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-
Infected Patients in Uganda. PLoS ONE 6(7): e21794. doi:10.1371/journal.pone.0021794
Editor: Landon Myer, University of Cape Town, South Africa
Received November 25, 2010; Accepted June 11, 2011; Published July 5, 2011
Copyright:  2011 Wanyenze et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by National Institute of Mental Health (1 R01 MH077512), Division of AIDS and Health and Behavior Research, Center for Mental
Health Research on AIDS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rwanyenze@hotmail.com
Introduction
Early diagnosis of HIV infection is critical for improvement of
HIV treatment outcomes [1–4]. Early diagnosis and treatment
also reduces the cost of medical care [5]. Additionally, studies have
suggested that early initiation of HIV treatment may have
important prevention benefits [6–8]. As such, the recent World
Health Organization (WHO) treatment guidelines recommend
initiation of HIV treatment at CD4#350, and several countries
have adopted these new guidelines [9,10]. However, treatment of
all individuals with CD4#350 will require earlier diagnosis of HIV
infection.
There has been a drive to scale-up HIV Counseling and Testing
(HCT) services in order to ensure early diagnosis and access to
HIV services including care and treatment as well as prevention
[11]. Increased access to HIV services is important for the
attainment of the Millennium Development Goals for HIV as well
as maternal and child health in sub-Saharan Africa [12]. Recent
reports show improvement in access to HCT, yet over 60% of
infected individuals globally remain unaware of their sero-status
[11]. In 2005, it was estimated that 80% of HIV infected
individuals in Uganda were unaware of their HIV status [13].
Research studies also reported late diagnosis and treatment of
HIV infected individuals [14]. Late initiation of HIV treatment in
sub-Saharan Africa has been associated with limited access to
treatment but could also be attributed to delays in diagnosis of
HIV infection and to delayed linkage to care after diagnosis
[14,15].
In an effort to scale-up access to HIV testing and linkage to care
many countries have adopted new HCT approaches, including
provider-initiated HIV testing and counseling (PITC) in the health
care setting and home based HIV counseling and testing
(HBHCT) [11,16,17]. In 2005, Uganda revised its HCT policy
to include PITC and HBHCT [18]. The proportion of individuals
who have tested and received HIV results in Uganda has increased
over time; estimated at 10% in 2003, 23% in 2006, and 38% in
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e217942008 [19–21]. In theory, increased access to HCT should lead to
earlier diagnosis of HIV but this has not been evaluated. We
provided HCT, determined prior HIV testing and medical history,
and performed CD4 counts for patients newly diagnosed with
HIV in the medical and emergency wards and the outpatient
medical clinics in Mulago National Referral Hospital in Uganda
and determined predictors of late HIV diagnosis.
Methods
Ethics Statement
The study was approved by Makerere University School of
Medicine Ethics Committee, Uganda National Council for
Science and Technology and the Institutional Review Boards of
the University of California San Francisco and University of
California Los Angeles. All study subjects provided written
informed consent prior to participation.
Study Setting
Mulago Hospital is the University teaching hospital of Makerere
University School of Medicine, and is one of two national referral
hospitals in Uganda. Mulago is the largest hospital in Uganda,
serving over one million patients a year, and was the first hospital
to initiate PITC in Uganda, in 2004 [22]. The medicine
department in the hospital has five general medical wards (three
non-private, one private, and one emergency ward) providing
services for in-patients. When patients come to the hospital, they
are screened in the emergency department. Adult patients are
referred to the emergency medical ward for overnight care.
Outpatient medical care is also provided within the medical
outpatient clinic. Follow-up HIV care for adult patients diagnosed
with HIV during hospitalization happens through several HIV
clinics within the hospital, including the Infectious Disease Clinic
(IDC) and the Mulago HIV clinic.
Procedures
This study was conducted as part of an ongoing randomised,
controlled trial to assess the impact of brief HIV counseling within
PITC versus detailed counseling on linkage to HIV care and HIV
risk reduction. Adult patients ($18 years) who had never tested for
HIV, or tested negative .1 year prior to recruitment, residing
within 25 kms of Mulago hospital, willing to receive a HIV test,
and possessing sufficient cognitive ability to participate in the study
were eligible.
Screening and enrollment
Following eligibility screening, written consent, baseline inter-
views and randomization, participants received HCT and CD4
testing immediately after HIV positive diagnosis. Between May
2008 and March 2010, 3613 patients were screened for eligibility
and 1216 were ineligible. The most common reasons for being
ineligible were testing for HIV within a year of screening (347), too
ill to participate in the study (214), residence outside the 25 km
radius (160), respondent planned to shift residence within a year of
recruitment (157), and age ,18 years (153). Of the 2,397 eligible
participants, 1,998 (83.4%) agreed to participate in the study.
Interview data was available for 1,966 participants at the time of
analysis. Of the 616 who were HIV infected, 612 had CD4 cell
counts done and were included in the analysis (Figure 1).
Laboratory testing
After the pre-test counseling, the counselor contacted the
laboratory technician to draw blood for HIV testing. HIV testing
was done using the serial testing algorithm with Determine (Abbott
Laboratories, Abbott Park, IL), Uni-Gold (Trinity Biotech,
Wicklow, Ireland) and Stat-Pak (Chembio Diagnostics). Blood
for baseline CD4 cell counts for HIV positive participants was
drawn immediately after disclosure of results. Quality control for
HIV testing and CD4 tests were done at the Makerere University-
Johns Hopkins University (MU-JHU) laboratory that is certified by
the College of American Pathologists. All HIV infected individuals
were provided with referrals to outpatient HIV clinics for follow-
up care. Study participants received their CD4 test results and
were advised to share the results with their providers.
Measurements
Demographic characteristics, prior medical and HIV testing
history, HIV risk perceptions and sexual risk behaviors were
collected using interviewer administered structured interviews.
Dependent variable
The primary dependent variable was late stage HIV at
diagnosis, defined as CD4#250, based on the current Ugandan
guidelines for ART eligibility.
Independent variables
Medical history and health seeking behavior. Participants
were asked about experiences with medical services, ever and in the
prior year, including hospital admissions, encounters with
Figure 1. Screening and enrollment of study subjects. This figure
shows the number of potential participants screened for eligibility, the
number of eligible subjects who agreed to participate and received HIV
testing, and the number of HIV infected participants who had CD4 tests.
doi:10.1371/journal.pone.0021794.g001
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providers, and diagnoses of tuberculosis or genital herpes. We also
created a summary variable to indicate whether or not the
participant had ever received medical treatment in a ‘‘non-
hospital setting’’ (from a pharmacy, home health care worker or
traditional healer).
Risk perception and HIV risk behaviors. Participants
were asked to describe the chances that they already had the HIV
virus to assess risk perception. Participants were also asked about
lifetime and recent (within 12 and 3 months of interview) sexual
activity, including numbers of sexual partners, and with each of
the five most recent sex partners in the prior 3 months, the
relationship type, the frequency of condom use, whether they
discussed HIV infection with this partner, and partner HIV status.
Partner HIV status was categorized as known negative, known
positive or unknown.
Anticipated outcomes of HIV diagnosis, disclosure, and
participation in HCT. Participants were asked about expected
positive and negative outcomes of being diagnosed with HIV
infection, and plans for disclosure in the event of HIV positive
sero-status. Potential positive outcomes of HIV testing and
participation in HCT included improved care from doctors,
access to HIV care and treatment, financial support, and increased
support from family and sexual partner. Potential negative
outcomes resulting from disclosure of HIV status included
discrimination, breakup of relationships and physical abuse. We
created a summary variable to indicate whether or not participants
anticipated at least one of the eight negative outcomes of
disclosure.
Other independent covariates. Socio-demographic variables
included participant age, gender, education, occupation, religion,
marital status, and income. Alcohol use was assessed by categorizing
participants in three categories: those who never drank alcohol, past
drinkers(those who last drank alcohol over one year ago),and current
drinkers (those who had consumed alcohol within the past year).
Heavy alcohol use was also assessed using the AUDIT-C, a three-
item screening tool used to identify hazardous drinking.
Analysis
As we were interested in late diagnosis of HIV, we limited all
analyses to HIV-positive study participants with available CD4
counts (n=612). The stage of diagnosis was first categorised as
CD4#250, .250–350, and .350. This was intended to capture
the proportion of participants eligible for treatment at a CD4#250
(current Uganda guidelines) as well as the cut-off of CD4#350, as
recommended by WHO. For all analyses, however, we compared
participants with late stage HIV at diagnosis (CD4#250, based on
current Uganda guidelines), to those who did not present with late
stage HIV. We conducted analyses using Chi-square tests to
determine whether socio-demographic characteristics, reasons for
testing, expected outcomes of testing, HIV risk behaviors or
perceptions, or medical history were associated with late stage
diagnosis. For variables that were also ordinal such as number of
sexual partners or perceived risk of being infected with HIV, we
additionally conducted the Armitage test for trend, excluding those
who declined to answer and reported these trends when they were
statistically significant. We used multivariate logistic regression to
identify correlates of late stage diagnosis. All covariates that were
associated with late presentation in the bivariate analyses at
statistical significance level of p,0.20 were included in the
preliminary multivariate model, with the exception of the
following three variables: reasons for HIV testing, diagnosis of
genital herpes within the past 5 years, and hospital admission
within the past year. Genital herpes diagnosis was excluded
because it was collinear with prior receipt of health care. In
addition, lifetime and past year hospitalization were collinear and
we included the former as a broad measure. We then reduced this
multivariate model using backwards selection, forward selection,
and stepwise selection (i.e. a combined backward and forward
method), using a cut-off of p#0.05 for inclusion/exclusion of
variables in the models. All three selection models retained the
same final explanatory variables as predictors of late stage HIV at
diagnosis.
Results
Univariate analysis
The majority of participants were female (62.9%, 385), 18–30
years old (49.4%, 302), and of primary level education (53.9%,
330), and about half had a monthly income of ,100,000 Uganda
shillings (equivalent to ,50 USD) (Table 1). Overall, 47.6% of
participants (291) had CD4 counts #250, 11.6% (71) had
CD4.250–350, and 40.9% (250) had CD4.350. The majority
(489, 81.8%) had never tested for HIV. Among those who had
previously tested for HIV, 65 (60.2%) tested.two years prior to
the current test while 43 (39.8%) tested within one to two years of
the current test.
Medical history, health seeking behavior, and reasons for
testing. Overall, 20.6% (126) of participants reported that they
had ever received treatment in a medical clinic, 66.7% (408) had
never received treatment in a medical clinic, while the rest were
not sure/did not know if they had received treatment at a clinic.
One hundred and twenty five (20.4%) had received treatment
from a drug store or pharmacy while 7.8% (48) had received
treatment from a traditional healer or herbalist. Only 70
participants (11.4%) reported having ever been admitted to a
hospital in their lifetime; 30 (42.9%) of these reported being
admitted within the past year. Twenty-seven (4.4%) reported a
diagnosis of tuberculosis within 5 years, and 33.5% reported
having ever been diagnosed with genital herpes. Wanting to know
the HIV status and concerns about illness/AIDS symptoms were
the main reasons for testing; 46.4% (284) and 46.2% (383),
respectively (Table 2).
HIV Risk perception and sexual behavior. Over half
(58%, 355) of the participants thought they could already be
infected with HIV, 12.1% (74) thought they were probably
already infected, and 10.6% (65) thought they were certainly
already infected. Overall, 73.8% (451) reported sexual activity
within 12 months; 29.7% (134) of these reported more than one
sexual partner. Among those who were sexually active in the past
3 months (56.1%, 343), 58.3% (200) reported that their most
recent partner was a spouse, and 50.4% (173) had discussed the
risk of HIV infection with their most recent partner. The vast
majority of those who were sexually active in the past 3 months
had either not used condoms or had used them inconsistently
(84.3%, 288); 14.9% (51) reported that their most recent sexual
partner was HIV positive, 22.2% (76) reported that their most
recent sexual partner was HIV negative, and 62.9% (215)
reported that they did not know the HIV status of their most
recent sexual partner (Table 3).
Anticipated outcomes of diagnosis with HIV infection. A
large proportion of the participants expected positive outcomes of
HIV diagnosis, disclosure, and participation in HCT. Participants
were especially optimistic regarding access to HIV services; 90.3%
(552) expected increased support from health workers, 98.7%
reported that diagnosis of HIV would cause doctors to take better
care of them, and 97.7% (597) expected to receive medications to
treat HIV. A large proportion (77.6%, 474) also anticipated
Late Stage HIV Diagnosis
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21794increased emotional support from their families and relatives upon
disclosure of HIV positive status (Table 4).
Despite the high numbers of expected positive outcomes, a
significant proportion of participants also anticipated negative
outcomes of being diagnosed with HIV; 46.4% (281) anticipated
at least one of eight negative outcomes, which included: breakup
of marriage (9.7%, 59), physical abuse by the spouse (13.9%, 85),
being neglected by their families (12.8%, 78), discrimination by
Table 1. Participant social and demographic characteristics by stage of HIV at diagnosis.
Characteristic
Total
n( % )
N=612
CD4.250
n( % )
N=321
CD4#250
n( % )
N=291 p-value
Sex 0.09
Male 227 (37.1) 109 (48.0) 118 (52.0)
Female 385 (62.9) 212 (55.1) 173 (44.9)
Age (median=31; IQR=26–38) 0.02
18–30 years 302 (49.4) 175 (58.0) 127 (42.1)
31–45 years 262 (42.8) 121 (46.2) 141 (53.8)
.45 years 48 (7.8) 25 (52.1) 23 (47.9)
Education 0.64
No formal education 35 (5.7) 22 (62.9) 13 (37.1)
Primary school 330 (53.9) 173 (52.4) 157 (47.6)
Secondary school 213 (34.8) 111 (52.1) 102 (47.9)
Primary or Ordinary Level professional 4 (0.7) 2 (50.0) 2 (50.0)
Technical/University 30 (4.9) 13 (43.3) 17 (56.7)
Occupation 0.80
Agriculture 32 (5.2) 16 (50.0) 16 (50.0)
Business 269 (44.0) 136 (50.6) 133 (49.4)
Other 252 (41.2) 138 (54.4) 114 (45.2)
Unemployed 59 (9.6) 31 (52.5) 28 (47.5)
Monthly income (median=60,000 USH; IQR=10,000–150,000) 0.41
,50,000 171 (27.9) 95 (55.6) 76 (44.4)
50,000–100,000 97 (15.9) 49 (50.5) 48 (49.5)
.100,000 134 (21.9) 65 (48.5) 69 (51.5)
Don’t know 205 (33.5) 111 (54.2) 94 (45.9)
Declined 5 (0.8) 1 (20.0) 4 (80.0)
Religion 0.86
Protestant 181 (29.6) 90 (49.7) 91 (50.3)
Catholic 216 (35.3) 113 (52.3) 103 (47.7)
Moslem 109 (17.8) 61 (56.0) 48 (44.0)
Saved/Pentecostal 96 (15.7) 51 (53.1) 45 (46.9)
Other 10 (1.6) 6 (60.0) 4 (40.0)
Marital status 0.69
Married 251 (41.0) 127 (50.6) 124 (49.4)
Married in the past 269 (44.0) 143 (53.2) 126 (46.8)
Never married 92 (15.0) 51 (55.4) 41 (44.6)
Alcohol consumption history 0.61
Never 220 (36.0) 117 (53.2) 103 (46.8)
Past drinker (.1 year ago) 115 (18.8) 55 (47.8) 60 (52.2)
Current drinker (within 1 year) 273 (44.7) 148 (54.2) 125 (45.8)
Don’t know 3 (0.5) 1 (33.3) 2 (66.7)
AUDIT-C alcohol risk group 0.57
No alcohol 401 (68.3) 204 (50.9) 197 (49.1)
Moderate risk 110 (18.7) 60 (54.6) 50 (45.5)
Hazardous risk 76 (13.0) 43 (56.6) 33 (43.4)
doi:10.1371/journal.pone.0021794.t001
Late Stage HIV Diagnosis
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e21794Table 2. Participant medical history and health seeking behavior by stage of HIV at diagnosis.
MEDICAL HISTORY AND HEALTH SEEKING BEHAVIOR
Total n (%)
N=612
CD4.250
n (%) N=321
CD4#250
n (%) N=291 p-value
Ever received treatment in a medical clinic ,0.01
Yes 126 (20.6) 45 (35.7) 81 (64.3)
No 408 (66.7) 228 (55.9) 180 (44.1)
Don’t know/Declined 78 (12.8) 48 (51.5) 30 (38.5)
Ever received treatment in a drug store/pharmacy ,0.01
Yes 125 (20.4) 38 (30.4) 87 (69.6)
No 406 (66.3) 233 (57.4) 173 (42.6)
Don’t know/Declined 81 (13.2) 50 (61.7) 31 (38.3)
Ever treated by a home health care worker ,0.01
Yes 12 (2.0) 1 (8.3) 11 (91.7)
No 522 (85.3) 272 (52.1) 250 (47.9)
Declined 78 (12.8) 48 (61.5) 30 (38.5)
Ever treated by a traditional healer/herbalist ,0.01
Yes 48 (7.8) 11 (22.9) 37 (77.1)
No 486 (79.4) 262 (53.9) 224 (46.1)
Declined 78 (12.8) 48 (61.5) 30 (38.5)
Ever received care from: pharmacy, home
health care worker, or traditional healer
,0.01
Yes 135 (22.1) 41 (30.4) 94 (69.6)
No 399 (65.2) 232 (58.2) 167 (41.9)
Declined 78 (12.8) 48 (61.5) 30 (38.5)
Ever admitted to the hospital ,0.01
Yes 70 (11.4) 20 (28.6) 50 (71.4)
No 459 (75.0) 251 (54.7) 208 (45.3)
Don’t know/Declined 83 (13.6) 50 (60.2) 33 (39.8)
Hospital admissions, past 12 months ,0.01
0 admissions 497 (81.2) 266 (53.5) 231 (46.5)
.=1 admissions 30 (4.9) 5 (16.7) 25 (83.3)
Don’t know 7 (1.1) 2 (28.6) 5 (71.4)
Declined 78 (12.8) 48 (61.5) 30 (38.5)
Tuberculosis diagnosis in past 5 years? 0.21
Yes 27 (4.4) 10 (37.0) 17 (63.0)
No 582 (95.1) 310 (53.3) 272 (46.7)
Don’t know/declined 3 (0.5) 1 (33.3) 2 (66.7)
Ever diagnosed with genital herpes 0.09
Yes 205 (33.5) 96 (46.8) 109 (53.2)
No 406 (66.3) 224 (55.2) 182 (44.8)
Recruitment site ,0.01
Outpatient 366 (59.8) 225 (61.5) 141 (38.5)
Medical Wards 149 (24.4) 51 (34.2) 98 (65.8)
3BEM/CAS 97 (15.9) 45 (46.4) 52 (53.6)
Main reasons for wanting to test ,0.01
AIDS symptoms/concerns about current illness 283 (46.2) 117 (41.3) 166 (58.7)
Past sexual behaviors (participant’s or partner’s) 32 (5.2) 24 (75.0) 8 (25.0)
Just wanted to know/plan for the future 284 (46.4) 174 (61.3) 110 (38.7)
Other reasons/declined 13 (2.1) 6 (46.2) 7 (53.9)
doi:10.1371/journal.pone.0021794.t002
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RISK PERCEPTION AND RISK BEHAVIORS
Total
n( % )
N=612
CD4.250
n( % )
N=321
CD4#250
n( % )
N=291 p-value
Chances that you already have HIV virus 0.20*
It almost certainly will not happen 53 (8.7) 28 (52.8) 25 (47.2)
It could happen 355 (58.0) 199 (56.1) 156 (43.9)
It probably will happen 74 (12.1) 35 (47.3) 39 (52.7)
It almost certainly will happen 65 (10.6) 27 (41.5) 38 (58.5)
Declined 65 (10.6) 32 (49.2) 33 (50.8)
Number of lifetime sexual partners (median=4; IQR=3–7) 0.86
None 1 (0.2) 0 (0.0) 1 (100.0)
1 partner 32 (5.2) 18 (56.3) 14 (43.8)
2–5 partners 338 (55.3) 178 (52.7) 160 (47.3)
.5 partners 157 (25.7) 82 (52.2) 75 (47.8)
Don’t know/Declined 83 (13.6) 43 (51.8) 40 (48.2)
Had sexual activity in 12 months 0.46
Yes 451 (73.8) 241 (53.4) 210 (46.6)
No 159 (26.0) 80 (50.3) 79 (49.7)
Declined 1 (0.2) 0 (0.0) 1 (100.0)
Number of sexual partners, 12 months (median=1; IQR=0–1) 0.45
None 166 (27.2) 83 (50.0) 83 (50.0)
1 partner 303 (49.6) 154 (50.8) 149 (49.2)
2–5 partners 128 (21.0) 76 (59.4) 52 (40.6)
.5 partners 6 (1.0) 4 (66.7) 2 (33.3)
Don’t know/Declined 8 (1.3) 4 (50.0) 4 (50.0)
Number of sexual partners, 3 months (median=1; IQR=0–1) 0.05
None 267 (43.8) 132 (49.4) 135 (50.6)
1 partner 291 (47.7) 153 (52.6) 138 (47.4)
2 partners 35 (5.7) 26 (74.3) 9 (25.7)
.=3 partners 17 (2.8) 10 (58.8) 7 (41.2)
Relationship with most recent sex partner (in 3 months) 0.04
No partner 267 (43.8) 132 (49.4) 135 (50.6)
Spouse 200 (32.8) 103 (51.5) 97 (48.5)
Mistress/girl/boy friend/lover 115 (18.9) 74 (64.4) 41 (36.7)
Other 28 (4.6) 12 (42.9) 16 (57.1)
Discussed risk of HIV infection with most recent partner 0.09
Yes 173 (28.4) 103 (59.5) 70 (40.5)
No 164 (26.9) 85 (51.8) 79 (48.2)
No partner, past 3 months 267 (43.8) 132 (49.4) 135 (50.6)
Don’t know/Declined 5 (0.8) 1 (20.0) 4 (80.0)
Condom use, with most recent sex partner 0.93
Always 54 (15.8) 29 (53.7) 25 (46.3)
Sometimes 32 (9.4) 17 (53.1) 15 (46.9)
Never 256 (74.9) 143 (55.9) 113 (44.1)
HIV status of most recent sex partner 0.51
Positive 51 (14.9) 29 (56.9) 22 (43.1)
Negative 76 (22.2) 46 (60.5) 30 (39.5)
Don’t know 215 (62.9) 114 (53.0) 101 (47.0)
*p-value test for trend when declined group was excluded = 0.04.
doi:10.1371/journal.pone.0021794.t003
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Table 5.
Comparisons between early and late diagnosis. Among
participants with late stage HIV infection, 48.5% (141) were 31–45
years old, compared to 37.7% (121) among those with CD4.250
(p=0.02). There were no other significant socio-demographic
differences between the two groups (Table 1). Of the participants
who reported having ever received treatment in a non-hospital
Table 4. Anticipated positive outcomes of diagnosis by stage of HIV at diagnosis.
ANTICIPATED POSITIVE OUTCOMES
Total
n( % )
N=612
CD4.250
n( % )
N=321
CD4#250
n( % )
N=291 p-value
Increased emotional support from family/relatives 0.73
Yes 474 (77.6) 248 (52.3) 226 (47.7)
No 106 (17.4) 54 (50.9) 52 (49.1)
Not applicable 12 (2.0) 8 (66.7) 4 (33.3)
Declined 19 (3.1) 11 (57.9) 8 (42.1)
Increased support from health professionals 0.58
Yes 552 (90.3) 294 (53.3) 258 (46.7)
No 32 (5.2) 13 (40.6) 19 (59.4)
Not applicable 2 (0.3) 1 (50.0) 1 (50.0)
Declined 25 (4.1) 13 (52.0) 12 (48.0)
Positive outcomes of participating in HCT/HIV diagnosis
Doctor(s) take better care 0.76
Yes 603 (98.7) 317 (52.6) 286 (47.4)
No 3 (0.5) 2 (66.7) 1 (33.3)
Declined 5 (0.8) 2 (40.0) 3 (60.0)
Receive medications to treat HIV 0.85
Yes 597 (97.7) 314 (52.6) 283 (47.4)
No 7 (1.2) 4 (57.1) 3 (42.9)
Declined 7 (1.2) 3 (42.9) 4 (57.1)
Receive financial assistance from the government 0.48
Yes 146 (23.9) 82 (56.2) 64 (43.8)
No 344 (56.3) 180 (52.3) 164 (47.7)
Declined 121 (19.8) 59 (48.8) 62 (51.2)
Receive financial assistance from other organizations 0.81
Yes 245 (40.1) 127 (51.8) 118 (48.2)
No 237 (38.8) 123 (51.9) 114 (48.1)
Declined 129 (21.1) 71 (55.0) 58 (45.0)
Join an HIV/AIDS support group 0.46
Yes 525 (85.9) 281 (53.5) 244 (46.5)
No 53 (8.7) 24 (45.3) 29 (54.7)
Declined 33 (5.4) 16 (48.5) 17 (51.5)
Continue to use other HIV/AIDS counseling services 0.16
Yes 577 (94.4) 308 (53.4) 269 (46.6)
No 19 (3.1) 6 (31.6) 13 (68.4)
Declined 15 (2.5) 7 (46.7) 8 (53.3)
Use hospice services 0.03
Yes 452 (74.0) 247 (54.7) 205 (45.4)
No 117 (19.2) 49 (41.9) 68 (58.1)
Declined 42 (6.9) 25 (59.5) 17 (40.5)
Receive treatment from a traditional healer or herbalist 0.62
Yes 80 (13.1) 46 (57.5) 34 (42.5)
No 507 (83.0) 262 (51.7) 245 (48.3)
Declined 24 (3.9) 13 (54.2) 11 (45.8)
doi:10.1371/journal.pone.0021794.t004
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late stage HIV compared to 232 (58.2%) among those who had
not received such care (p,0.01) (Table 2). Among the reasons for
testing for HIV, concerns about ill health were more prominent
among individuals with late diagnosis (p,0.01). The site of
participant recruitment was associated with late stage HIV
Table 5. Anticipated negative outcomes of diagnosis by stage of HIV at diagnosis.
ANTICIPATED NEGATIVE OUTCOMES
Total
n( % )
N=612
CD4.250
n( % )
N=321
CD4#250
n( % )
N=291 p-value
Anticipates at least one negative outcome of disclosing HIV+ status 0.47
Yes 281 (46.4) 144 (51.3) 137 (48.8)
No 325 (53.6) 176 (54.2) 149 (45.9)
Negative outcomes of disclosing HIV+ status
Breakup of marriage 0.05
Yes 59 (9.7) 25 (42.4) 34 (57.6)
No 167 (27.3) 90 (53.9) 77 (46.1)
Not applicable 344 (56.3) 191 (55.5) 153 (44.5)
Declined 41 (6.7) 15 (36.6) 26 (63.4)
Physical abuse by spouse/sexual partner 0.83
Yes 85 (13.9) 42 (49.4) 43 (50.6)
No 267 (43.7) 142 (53.2) 125 (46.8)
Not applicable 223 (36.5) 116 (52.0) 107 (48.0)
Declined 36 (5.9) 21 (58.3) 15 (41.7)
Neglected by family 0.76
Yes 78 (12.8) 44 (56.4) 34 (43.6)
No 491 (80.4) 257 (52.3) 234 (47.7)
Not applicable 9 (1.5) 5 (55.6) 4 (44.4)
Declined 33 (5.4) 15 (45.5) 18 (54.6)
Disowned by family 0.79
Yes 42 (6.9) 21 (50.0) 21 (50.0)
No 547 (89.5) 288 (52.7) 259 (47.4)
Not applicable 9 (1.5) 6 (66.7) 3 (33.3)
Declined 13 (2.1) 6 (46.2) 7 (53.9)
Discrimination by health professionals 0.53
Yes 27 (4.4) 16 (59.3) 11 (40.7)
No 531 (86.9) 276 (52.0) 255 (48.0)
Not applicable 4 (0.7) 1 (25.0) 3 (75.0)
Declined 49 (8.0) 28 (57.1) 21 (42.9)
Breakup of sexual relationships 0.29
Yes 150 (24.6) 76 (50.7) 74 (49.3)
No 213 (34.9) 122 (57.3) 91 (42.7)
Not applicable 194 (31.8) 99 (51.0) 95 (49.0)
Declined 54 (8.8) 24 (44.4) 30 (55.6)
Discrimination by employers 0.35
Yes 39 (6.4) 19 (48.7) 20 (51.3)
No 236 (38.6) 116 (49.2) 120 (50.9)
Not applicable 318 (52.5) 178 (56.0) 140 (44.0)
Declined 18 (3.0) 8 (44.4) 10 (55.6)
Estranged by peers 0.63
Yes 86 (14.1) 41 (47.7) 45 (52.3)
No 449 (73.5) 237 (52.8) 212 (47.2)
Not applicable 26 (4.3) 16 (61.5) 10 (38.5)
Declined 50 (8.2) 27 (54.0) 23 (46.0)
doi:10.1371/journal.pone.0021794.t005
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the medical wards had CD4#250 while only 38.5% (141) of those
who were recruited from the outpatient clinics had CD4#250
(p,0.01). When we conducted a test for trend among those who
did not decline the question, there was an inverse relationship
between belief that one was infected with HIV and CD4 cell count
at testing (Table 3). There was borderline statistical evidence that
more of the participants who presented late, compared to those
who did not present late, anticipated that disclosing HIV+ status
would break up a marriage (p=0.05) (Table 5).
Multivariate predictors of late diagnosis
We conducted forward, backward, and stepwise selection and
all three methods resulted in the same final model. In the final
multivariate model, only three variables: age, receipt of non-
medical health care, and the number of recent sexual partners
were the only variables independently associated with late
presentation. Participants who were 31–45 years old had 1.6
times the odds of being diagnosed late compared to participants
who were 18–30 years old (95% CI: 1.1–2.3); Table 6. Participants
who reported ever receiving care in a non-medical setting (home,
traditional healer and drug stores) also had significantly increased
odds of late stage diagnosis, compared to those who had never
received care from such providers (OR=3.2; 95%CI: 2.1–4.9).
Compared to participants with no sexual partners in the past three
months, those reporting two partners had decreased odds of late
diagnosis (OR=0.3; 95%CI: 0.1–0.7). Participants with three or
more partners also had decreased odds of late diagnosis, although
this association was not statistically significant (p=0.3).
Discussion
We found that half of the newly diagnosed HIV infected
patients at the national referral hospital in Uganda had late stage
HIV infection. Upon multivariate analysis, older age and ever
having received health care from a non-medical provider were
associated with higher odds of late presentation, while being
sexually active was associated with earlier presentation. Individuals
within the 31–45 year age group were more likely to be diagnosed
late possibly because they had been infected earlier. Similarly,
those who had received care from a non-medical provider were
more likely to be diagnosed late because the illness for which they
sought care could have been HIV related, or because they did not
go to medical facilities that offered HIV testing. Individuals who
reported two sexual partners were less likely to have late HIV
infection compared to those who reported no partners, possibly
because such persons may also have experienced previous sexually
transmitted infections and therefore had more contact with health
facilities.
A significant proportion of those with late stage HIV (27.8%)
had received care at a medical clinic and a similar proportion
(29.9%) had previously received treatment from a pharmacy/drug
store. Fewer individuals had prior encounters with traditional
healers (7.8%) or home health workers (2.0%). These findings
highlight several gaps and missed opportunities for HIV diagnosis,
including: 1) Failure to diagnose HIV infection for infected
individuals who attended medical clinics; and 2) A missed
opportunity to make a diagnosis for HIV (or any other illness)
for those who received care at the pharmacies and drug shops,
since these outlets only sell drugs largely on request from sick
individuals. Strengthening and expansion of PITC to all health
units may reduce missed opportunities for HIV diagnosis, for those
individuals who do make contact with these facilities. The initial
scale-up of PITC focused more on the high HIV prevalence
facilities, including medical and tuberculosis wards [22]. We found
that two thirds of the participants in the medical wards had late
stage HIV compared to one third of the outpatients. In
comparison to the medical wards, HIV testing in outpatient units
may provide a better opportunity for earlier HIV diagnosis [23].
Notably, two thirds of the newly diagnosed HIV infected
individuals had never attended a medical clinic at all and could
therefore not have benefitted from the expansion of provider
initiated HIV testing within health facilities. Late stage diagnosis
was also associated with receiving care from a non-medical facility.
This indicates that a significant proportion of HIV infected
individuals may not make contact with health facilities until late in
their illness. Facility based interventions may not reach out to all
individuals that require HCT because those who do not have
health problems or are not ill will not go to health facilities. Also,
some individuals with health problems may opt to seek care
elsewhere. An estimated 13% of Ugandans who need and seek
Table 6. Multivariate predictors of late stage HIV at diagnosis (CD4#250).
Characteristic Odds Ratio 95% Confidence Interval
Age
18–30 years 1.00 —
31–45 years 1.63 (1.15, 2.30)
.45 years 1.00 (0.52, 1.92)
Ever received health care from a pharmacy, home health worker, or a traditional healer
Never 1.00 —
Ever 3.20 (2.09, 4.91)
Declined 0.86 (0.52, 1.44)
Number of sex partners, past three months
0 partners 1.00 —
1 partner 0.87 (0.62, 1.24)
2 partners 0.30 (0.13, 0.70)
3 or more partners 0.59 (0.20, 1.73)
doi:10.1371/journal.pone.0021794.t006
Late Stage HIV Diagnosis
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e21794healthcare do so from drugstores [24]. The scale-up of PITC also
initially targeted public facilities. Yet, only 29% of Ugandans seek
healthcare at public facilities while 46% go to private clinics [24].
Scale-up of PITC and other facility based interventions should
involve the private sector. Augmentation of PITC with community
and home based HIV testing approaches will also be critical in
expanding access to early diagnosis and care. A study that
compared four HCT approaches in Uganda found that the HCT
approaches were complementary. While a larger proportion of
infected individuals was identified through PITC, HBHCT
identified HIV infected individuals at an earlier stage of infection
[25]. Additionally, providers at pharmacies, drug stores, and
traditional healers should encourage people to seek additional
services including HIV testing at medical facilities. Strategies to
improve early diagnosis will be critical to the current efforts of
early initiation of HIV treatment – most of the participants in this
study (59%) had CD4 counts of ,350.
Several previous studies showed that low perception of risk of
being infected with HIV may be associated with failure to utilise
HIV testing services [26]. We found an inverse relationship
between risk perception and CD4 count on univariate analysis,
suggesting that many do not feel that they are at risk until they
become ill. However, risk perception was not statistically
significant in the multivariate models, possibly due to an
association with seeking medical care. In addition to the suspicion
that they could be HIV infected, over 95% of the participants in
this study noted the medical benefits of HIV diagnosis, including
improved care and access to HIV treatment. Many also expected
increased support from their families if they were to test positive.
Although the proportion of participants mentioning each of the
negative social outcomes of HIV disclosure was quite small,
ranging between 6%–14%, about 46% anticipated at least one
negative social outcome. It is possible that these negative social
issues may have been a deterrent to testing [26,27]. In a related
study conducted in the same hospital, we found that the frequency
of negative social outcomes was actually quite low [28]. However,
these fears, real or exaggerated, need to be addressed through
efforts to minimize stigma and discrimination, so that they do not
hinder uptake of HIV services.
These data show significant HIV risk behavior. Most of the
newly diagnosed HIV infected individuals were still sexually active
and had partners who were either known HIV negative or of
unknown HIV status. Yet, consistent condom use was very low.
Diagnosis of HIV infection may lead to increased condom use
since studies have shown less risky behavior including increased
condom use following HIV diagnosis [29]. Better still, initiation of
HIV treatment may reduce the risk of HIV transmission to sexual
partners [8,9,29].
While we had a high response rate, our sample of individuals at
a national referral hospital in an urban setting may not represent
the larger Ugandan population. Also, these data were derived
from a study which was not primarily designed to assess reasons for
delayed diagnosis, and do not fully address some potential reasons
for delayed diagnosis, including access to HIV testing. We believe
that the lack of strong associations may be due to the fact that
many of the participants in this study came to the hospital
primarily to seek medical care rather than HIV testing. It is
possible that the predictors of late diagnosis would be different if
individuals who seek HIV testing late were compared with those
who seek testing early. However, the study highlights issues that
are critical to the mix of HIV testing approaches for the scale-up of
early HIV diagnosis and linkage to HIV prevention and
treatment.
In summary, this study highlights the need to strengthen PITC,
and to augment the current PITC scale-up with community or
other non-health facility based HCT approaches, as well as
providing an environment that minimises the negative social
outcomes of HIV diagnosis and disclosure of HIV status.
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